Avestria Ventures

Avestria invests in women’s health and female-led life science ventures. We define women’s health as conditions affecting women exclusively (such as menopause), differently (such as cardiovascular disease), or disproportionately (such as Alzheimer’s). Women are dominant in healthcare as founders, decision-makers, patients, spenders, and workers. And yet, only 1% of all venture capital funding for healthcare goes to women’s health companies and only 1.9% of all venture capital funding went to female founders in 2022. To us, those figures show that these markets - women’s healthcare and female founders in the life sciences - are overlooked and undervalued. We seek out early-stage businesses with a product or service that utilizes technology and/or data to improve the quality of healthcare, improve access, lower costs, or empower patients. In order to achieve commercial success, these businesses must be evidenced-based, induce clinical or behavioral change, possess scalable commercialization plans that account for healthcare policy, reimbursement, and the existing infrastructure, and possess a sustainable competitive advantage.